Bionano Genomics (BNGO) Share-based Compensation (2017 - 2026)
Bionano Genomics (BNGO) posted Share-based Compensation of $670000.0 for Q1 2026, down 27.65% sequentially from $926000.0 in Q4 2025, and down 57.78% YoY from $1.6 million in Q1 2025.
Bionano Genomics (BNGO) Share-based Compensation (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Share-based Compensation for 10 years, with the latest figure at $670000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 57.78% year-over-year to $670000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 56.46% YoY) and the FY2025 annual result came in at $4.5 million, down 53.43% from the prior year.
- Share-based Compensation slipped to $670000.0 in Q1 2026 per BNGO's latest filing, from $926000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $21.9 million in Q4 2022 and troughed at $4000.0 in Q2 2022.
- A 5-year average of $3.3 million and a median of $2.1 million in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 96.55% in 2022, then soared 98200.0% in 2023.
- Over 5 years, Share-based Compensation stood at $21.9 million in 2022, then slumped by 84.6% to $3.4 million in 2023, then tumbled by 42.59% to $1.9 million in 2024, then slumped by 52.17% to $926000.0 in 2025, then slipped by 27.65% to $670000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $670000.0, $926000.0, and $941000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.90 Bn | 128.68 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.32 Bn | 51.46 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.72 Bn | 34.37 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 28.61 Bn | 25.93 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 24.99 Bn | 24.56 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.38 Bn | 14.98 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Bionano Genomics | 13.97 Mn | 4.04 Mn | 4.31 Mn | 970,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 970,000.00 |
| Jun 30, 2026 | 970,000.00 |
| Mar 31, 2026 | 670,000.00 |
| Mar 31, 2026 | 670,000.00 |
| Dec 31, 2025 | 926,000.00 |
| Dec 31, 2025 | 926,000.00 |
| Sep 30, 2025 | 941,000.00 |
| Sep 30, 2025 | 941,000.00 |
| Jun 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Dec 31, 2024 | 1.94 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Mar 31, 2024 | 3.02 Mn |